Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewAgingEndocrinologyMetabolism Open Access | 10.1172/jci.insight.197310

p21-senescent cells drive pancreatic islet dysfunction through targetable paracrine signaling in type 2 diabetes

Kanako Iwasaki,1 Priscila Carapeto,1 Cristian Abarca,1 Francesko Hela,1 Stephanie Sanjines,1 Sebastian Pena,1 Sandra Le,1 Hui Pan,1 Maya Jackson,1 Christopher Cahill,1 Ayush Midha,1 Juliana Alcoforado Diniz,2 Dylan Baker,2 Sergii Domanskyi,2 Sara Espinoza,3 Alejandro Pena,4 Francisco G. Cigarroa,4 Jillian L. Woodworth,4 Jeffrey H. Chuang,2 Vesna D. Garovic,5 James L. Kirkland,6 Tamara Tchkonia,6 Nicolas Musi,3 George A. Kuchel,7 Paul Robson,2 and Cristina Aguayo-Mazzucato1

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Iwasaki, K. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Carapeto, P. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Abarca, C. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Hela, F. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Sanjines, S. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Pena, S. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Le, S. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Pan, H. in: PubMed | Google Scholar |

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Jackson, M. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Cahill, C. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Midha, A. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Diniz, J. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Baker, D. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Domanskyi, S. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Espinoza, S. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Pena, A. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Cigarroa, F. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Woodworth, J. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Chuang, J. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Garovic, V. in: PubMed | Google Scholar |

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Kirkland, J. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Tchkonia, T. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Musi, N. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Kuchel, G. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Robson, P. in: PubMed | Google Scholar

1Joslin Diabetes Center/Harvard Medical School, Boston, United States of America

2The Jackson Laboratory for Genomic Medicine, Farmington, United States of America

3Center for Translational Geroscience, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

4UT Health San Antonio Transplant Center, San Antonio, United States of America

5Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, United States of America

6Center for Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America

7UConn Center on Aging, UConn Health, Farmington, United States of America

Find articles by Aguayo-Mazzucato, C. in: PubMed | Google Scholar

Published June 9, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.197310.
Copyright © 2026, Iwasaki et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 9, 2026 - Version history
View PDF
Abstract

Cellular senescence is an irreversible stress response, which leads to loss of cellular function and remodelling of the cellular secretory profile. In humans, pancreatic β-cells undergo cellular senescence during the progression to type 2 diabetes (T2D). However, the mechanism linking β-cell senescence to islet dysfunction remains unknown and thus, the therapeutic potential of targeting senescent cells in T2D is not established. Herein, we identified a subpopulation of senescent β-cells expressing p21, which emerged early in the progression of T2D in humans and mice. Spatial transcriptomics, and proteomics analyses confirmed senescence and loss of cellular identity in this subpopulation in humans. Functional analysis revealed lack of glucose responsiveness, high basal insulin secretion, and transcription of senescence-associated secretory phenotype (SASP) factors. SASP factors from p21+ β-cells induced secondary senescence in neighbouring cells, characterized by dysfunction and loss of identity. Janus kinase inhibitors (JAKi) counteracted the induction of secondary senescence and restored β-cell function in islets from humans with T2D and in high-fat diet-fed mice. These findings reveal the critical role of p21+ β-cells in T2D pathogenesis and the therapeutic potential of targeting this pathophysiological process.

Supplemental material

View

Version history
  • Version 1 (June 9, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts